Trial Profile
Study of saroglitazar in treatment of prediabetes with dyslipidemia - STOP-D
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Saroglitazar (Primary)
- Indications Dyslipidaemias; Prediabetic state
- Focus Therapeutic Use
- 30 Aug 2016 New trial record